Pascal Turlure
Limoges, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.
Journal: Leukemia
Published: April 14, 2026
Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.
Journal: Blood cancer journal
Published: March 10, 2026
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.
Journal: Bone marrow transplantation
Published: December 25, 2025
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC.
Journal: Bone marrow transplantation
Published: December 11, 2025
Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure.
Journal: Bone marrow transplantation
Published: December 01, 2025
ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.
Journal: Bone marrow transplantation
Published: November 30, 2025
Gain and Loss of FLT3 Mutations in Patients with Acute Myeloid Leukemia: A Noninterventional Cohort Study (CLEVO).
Journal: Oncology and therapy
Published: November 06, 2025
Intermediate-Dose Cytarabine as Postinduction AML Therapy.
Journal: NEJM evidence
Published: June 24, 2025
Last Updated: 09/26/2026